SignatureFD’s Alto Neuroscience ANRO Stock Holding History

SignatureFD’s Portfolio ANRO Stock Details ANRO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-41	Closed	-$922	–	3652
2026 Q1	$922	Sell	41 -1,024	-96%	-$19K	﹤0.01%	3225
2025 Q4	$19K	Buy	+1,065	New	+$13.4K	﹤0.01%	2143

Other funds holding ANRO

Revisor Wealth Management Akron, Ohio $416M AUM 25.24% 1-Year Est. Return

GK Wealth Management Reno, Nevada $190M AUM 66.42% 1-Year Est. Return

Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

Torren Management San Diego, California $197M AUM

SBI Securities Tokyo, Japan $4.4B AUM 74.25% 1-Year Est. Return

Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return

GAMMA Investing Foster City, California $2.69B AUM 42.78% 1-Year Est. Return

SignatureFD's ANRO Position: Q2 2026 in Review

SignatureFD sold out of Alto Neuroscience (ANRO) in Q2 2026, closing a stake of 41 shares — an estimated $922 sold.

SignatureFD first reported a position in ANRO in Q4 2025 and held it in 2 quarters. The position peaked at $19K in Q4 2025. 7 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

SignatureFD reported no remaining Alto Neuroscience position as of Q2 2026 after selling out during the quarter.
SignatureFD sold 41 Alto Neuroscience shares in Q2 2026, an estimated $922.
SignatureFD first reported a position in Alto Neuroscience in Q4 2025 and held it in 2 quarters.
SignatureFD's Alto Neuroscience position peaked at $19K in Q4 2025.
7 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on SignatureFD's 13F filing for Q2 2026, filed 24 Jul 2026.